植入材料与患者年龄对重型创伤性脑损伤去骨瓣减压术后二期颅骨成形术长期结局的影响
该研究回顾性分析1984至2015年间156例因重型创伤性脑损伤行去骨瓣减压术后接受二期颅骨成形术的患者,按是否发生需手术干预的并发症分组。Cox回归显示聚甲基丙烯酸甲酯植入物较自体颅骨骨瓣植入物的翻修率更低(HR 0.2,95%CI 0.1至1.0,p=0.04),18至65岁患者较18岁以下或65岁以上患者并发症需手术治疗的风险更低(HR 0.4,95%CI 0.2至0.9,p=0.02)。结论认为植入材料和患者年龄是独立预测二期颅骨成形术长期结局的最相关参数。
要点
- 聚甲基丙烯酸甲酯植入物较自体颅骨骨瓣植入物的翻修率更低(HR 0.2,95%CI 0.1至1.0,p=0.04)。
- 18至65岁患者较18岁以下或65岁以上患者并发症需手术治疗的风险更低(HR 0.4,95%CI 0.2至0.9,p=0.02)。
- 性别、颅骨成形术时机、创伤性脑损伤严重程度和颅骨缺损大小未影响翻修率。
核心结论
- 植入材料和患者年龄是独立预测二期颅骨成形术长期结局的最相关参数。
- 使用聚甲基丙烯酸甲酯与较自体颅骨骨瓣更低的翻修率相关,可能为选定的创伤性颅骨缺损患者提供治疗获益。
研究设计与样本
- 回顾性分析1984年至2015年间156例因重型创伤性脑损伤行去骨瓣减压术后接受二期颅骨成形术的患者,按发生需手术干预的并发症分组。
主要发现
- 聚甲基丙烯酸甲酯植入物患者较自体颅骨骨瓣植入物患者的翻修率更低(HR 0.2,95%CI 0.1至1.0,p=0.04)。
- 18至65岁患者较18岁以下或65岁以上患者发生需手术治疗的并发症风险更低(HR 0.4,95%CI 0.2至0.9,p=0.02)。
- 翻修率不受性别(p=0.88)、颅骨成形术时机(p=0.53)、创伤性脑损伤严重程度(p=0.86)或颅骨缺损大小(p=0.16)影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Secondary cranioplasty (CP) is considered to support the neurological recovery of patients after decompressive craniectomy (DC), but the treatment success might be limited by complications associated to confounders, which are not yet fully characterized. The aim of this study was to identify the most relevant factors based on the necessity to perform revision surgeries. METHODS: Data from 156 patients who received secondary CP following DC for severe traumatic brain injury (TBI) between 1984 and 2015 have been retrospectively analyzed and arranged into cohorts according to the occurrence of complications requiring surgical intervention. RESULTS: Cox regression analysis revealed a lower revision rate in patients with polymethylmethacrylate (PMMA) implants than in patients with autologous calvarial bone (ACB) implants (HR 0.2, 95% CI 0.1 to 1.0, p = 0.04). A similar effect could be observed in the population of patients aged between 18 and 65 years, who had a lower risk to suffer complications requiring surgical treatment than individuals aged under 18 or over 65 years (HR 0.4, 95% CI 0.2 to 0.9, p = 0.02). Revision rates were not influenced by the gender (p = 0.88), timing of the CP (p = 0.53), the severity of the TBI (p = 0.86), or the size of the cranial defect (p = 0.16). CONCLUSIONS: In this study, the implant material and patient age were identified as the most relevant parameters independently predicting the long-term outcome of secondary CP. The use of PMMA was associated with lower revision rates than ACB and might provide a therapeutic benefit for selected patients with traumatic cranial defects.
引用
- Hamböck M, Hosmann A, Seemann R, et al. The impact of implant material and patient age on the long-term outcome of secondary cranioplasty following decompressive craniectomy for severe traumatic brain injury. Acta Neurochir (Wien). 2020. PMID: 32025876. doi:10.1007/s00701-020-04243-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。